Studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced immune suppression and decreased resistance to infection: endotoxin hypersensitivity, serum zinc concentrations and effect of thymosin treatment.
D000818:Animals; D004147:Dioxins / Q000494:pharmacology*; D004342:Drug Hypersensitivity; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D006967:Hypersensitivity / Q000276:immunology*; D007166:Immunosuppressive Agents; D008088:Listeriosis / Q000276:immunology; D051379:Mice; D009580:Nitroblue Tetrazolium / Q000378:metabolism; D010084:Oxidation-Reduction; D000072317:Polychlorinated Dibenzodioxins / Q000494:pharmacology*; D013947:Thymosin / Q000494:pharmacology*; D013951:Thymus Hormones / Q000494:pharmacology*; D015032:Zinc / Q000097:blood*
D004147:Dioxins; D004731:Endotoxins; D007166:Immunosuppressive Agents; D000072317:Polychlorinated Dibenzodioxins; D013951:Thymus Hormones; D009580:Nitroblue Tetrazolium; D013947:Thymosin; D015032:Zinc